| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| EWCZEuropean Wax Center, Inc. | 189.63M | 4.34 | 19.73 | -1.86% | 5.32% | 10.72% | 29.52% | 4.16 |
| SKINThe Beauty Health Company | 198.9M | 1.56 | -4.33 | -16% | -3.89% | -17.89% | 4.7% | 10.97 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Sales/Revenue | 166.62M | 119.09M | 260.09M | 365.88M | 397.99M | 334.29M |
| Revenue Growth % | - | -0.29% | 1.18% | 0.41% | 0.09% | -0.16% |
| Cost of Goods Sold | 60.11M | 51.89M | 81.55M | 117.1M | 242.88M | 152M |
| COGS % of Revenue | 0.36% | 0.44% | 0.31% | 0.32% | 0.61% | 0.45% |
| Gross Profit | 106.51M | 67.2M | 178.54M | 248.78M | 155.11M | 182.3M |
| Gross Margin % | 0.64% | 0.56% | 0.69% | 0.68% | 0.39% | 0.55% |
| Gross Profit Growth % | - | -0.37% | 1.66% | 0.39% | -0.38% | 0.18% |
| Operating Expenses | 93.05M | 84.38M | 218.47M | 274.62M | 286.03M | 250.07M |
| OpEx % of Revenue | 0.56% | 0.71% | 0.84% | 0.75% | 0.72% | 0.75% |
| Selling, General & Admin | 88.44M | 80.97M | 210.27M | 266.18M | 275.93M | 243.77M |
| SG&A % of Revenue | 0.53% | 0.68% | 0.81% | 0.73% | 0.69% | 0.73% |
| Research & Development | 4.61M | 3.41M | 8.2M | 8.44M | 10.1M | 6.3M |
| R&D % of Revenue | 0.03% | 0.03% | 0.03% | 0.02% | 0.03% | 0.02% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 13.46M | -17.18M | -39.93M | -25.84M | -130.92M | -67.77M |
| Operating Margin % | 0.08% | -0.14% | -0.15% | -0.07% | -0.33% | -0.2% |
| Operating Income Growth % | - | -2.28% | -1.32% | 0.35% | -4.07% | 0.48% |
| EBITDA | 27.2M | -2.78M | -22M | -2.97M | -96.24M | -38.3M |
| EBITDA Margin % | 0.16% | -0.02% | -0.08% | -0.01% | -0.24% | -0.11% |
| EBITDA Growth % | - | -1.1% | -6.91% | 0.87% | -31.43% | 0.6% |
| D&A (Non-Cash Add-back) | 13.74M | 14.4M | 17.93M | 22.87M | 34.67M | 29.48M |
| EBIT | 14.16M | -17.21M | -368.86M | 58.73M | -88.24M | -19.14M |
| Net Interest Income | -17.09M | -21.27M | -11.74M | -4.22M | 9.52M | 6.23M |
| Interest Income | 0 | 0 | 39K | 9.18M | 23.17M | 16.64M |
| Interest Expense | 17.09M | 21.27M | 11.78M | 13.39M | 13.65M | 10.41M |
| Other Income/Expense | -16.4M | -21.3M | -340.71M | 71.18M | 29.03M | 38.22M |
| Pretax Income | -2.94M | -38.48M | -380.64M | 45.34M | -101.89M | -29.55M |
| Pretax Margin % | -0.02% | -0.32% | -1.46% | 0.12% | -0.26% | -0.09% |
| Income Tax | -1.3M | -9.31M | -1.88M | 1.11M | -1.77M | -452K |
| Effective Tax Rate % | 0.56% | 0.76% | 1% | 0.98% | 0.98% | 0.98% |
| Net Income | -1.64M | -29.18M | -378.76M | 44.22M | -100.12M | -29.1M |
| Net Margin % | -0.01% | -0.24% | -1.46% | 0.12% | -0.25% | -0.09% |
| Net Income Growth % | - | -16.81% | -11.98% | 1.12% | -3.26% | 0.71% |
| Net Income (Continuing) | -1.64M | -29.18M | -378.76M | 44.22M | -100.12M | -29.1M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.05 | -0.85 | -3.67 | -0.23 | -0.76 | -0.36 |
| EPS Growth % | - | -15.67% | -3.32% | 0.94% | -2.3% | 0.53% |
| EPS (Basic) | -0.05 | -0.85 | -3.67 | 0.30 | -0.76 | -0.23 |
| Diluted Shares Outstanding | 32.14M | 34.29M | 102.11M | 148.51M | 131.68M | 142.49M |
| Basic Shares Outstanding | 32.14M | 34.29M | 102.11M | 147.55M | 131.68M | 123.83M |
| Dividend Payout Ratio | - | - | - | - | - | - |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Total Current Assets | 54.17M | 59.09M | 1B | 783.27M | 698.25M | 477.12M |
| Cash & Short-Term Investments | 7.31M | 9.49M | 901.89M | 568.2M | 523.02M | 370.06M |
| Cash Only | 7.31M | 9.49M | 901.89M | 568.2M | 523.02M | 370.06M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 23.72M | 23.19M | 51.42M | 77.77M | 55.03M | 28.46M |
| Days Sales Outstanding | 51.96 | 71.06 | 72.17 | 77.59 | 50.47 | 31.08 |
| Inventory | 19.43M | 23.2M | 35.26M | 109.66M | 91.32M | 69.11M |
| Days Inventory Outstanding | 118.01 | 163.2 | 157.82 | 341.81 | 137.24 | 165.96 |
| Other Current Assets | 0 | 2.58M | 0 | 27.65M | 28.88M | 9.49M |
| Total Non-Current Assets | 172.18M | 163.74M | 217.91M | 219.81M | 230.86M | 208.56M |
| Property, Plant & Equipment | 10.8M | 9.19M | 31.18M | 33.82M | 26.35M | 19.57M |
| Fixed Asset Turnover | 15.43x | 12.96x | 8.34x | 10.82x | 15.11x | 17.08x |
| Goodwill | 98.52M | 98.53M | 123.69M | 124.59M | 125.82M | 123.5M |
| Intangible Assets | 60.29M | 50.94M | 56.01M | 46.39M | 62.12M | 47.51M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2.34M | 4.81M | 6.71M | 14.19M | 16.04M | 14.09M |
| Total Assets | 226.35M | 222.84M | 1.22B | 1B | 929.11M | 685.68M |
| Asset Turnover | 0.74x | 0.53x | 0.21x | 0.36x | 0.43x | 0.49x |
| Asset Growth % | - | -0.02% | 4.47% | -0.18% | -0.07% | -0.26% |
| Total Current Liabilities | 37.82M | 30.93M | 76.44M | 71.71M | 115.01M | 68.15M |
| Accounts Payable | 14.26M | 18.48M | 29.05M | 28.47M | 44.77M | 21.94M |
| Days Payables Outstanding | 86.57 | 130.02 | 130.02 | 88.73 | 67.28 | 52.69 |
| Short-Term Debt | 8.93M | 512K | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 450K | 1000K |
| Other Current Liabilities | 0 | 2.46M | 18.28M | 5.64M | 25.01M | 2.14M |
| Current Ratio | 1.43x | 1.91x | 13.09x | 10.92x | 6.07x | 7.00x |
| Quick Ratio | 0.92x | 1.16x | 12.63x | 9.39x | 5.28x | 5.99x |
| Cash Conversion Cycle | 83.4 | 104.24 | 99.97 | 330.66 | 120.43 | 144.35 |
| Total Non-Current Liabilities | 189.74M | 221.87M | 840.07M | 764.32M | 754.72M | 565.73M |
| Long-Term Debt | 180.85M | 216.02M | 729.91M | 734.14M | 738.37M | 552.2M |
| Capital Lease Obligations | 276K | 0 | 12.78M | 12.69M | 9.32M | 10.81M |
| Deferred Tax Liabilities | 8.29M | 3.99M | 3.56M | 2.01M | 702K | 396K |
| Other Non-Current Liabilities | 325K | 1.85M | 93.82M | 15.47M | 6.32M | 2.32M |
| Total Liabilities | 227.56M | 252.79M | 916.51M | 836.03M | 869.72M | 633.88M |
| Total Debt | 190.2M | 216.54M | 746.41M | 751.79M | 752.29M | 568.16M |
| Net Debt | 182.89M | 207.05M | -155.48M | 183.59M | 229.26M | 198.09M |
| Debt / Equity | - | - | 2.47x | 4.50x | 12.67x | 10.97x |
| Debt / EBITDA | 6.99x | - | - | - | - | - |
| Net Debt / EBITDA | 6.72x | - | - | - | - | - |
| Interest Coverage | 0.79x | -0.81x | -3.39x | -1.93x | -9.59x | -6.51x |
| Total Equity | -1.21M | -29.96M | 302.3M | 167.05M | 59.39M | 51.8M |
| Equity Growth % | - | -23.8% | 11.09% | -0.45% | -0.64% | -0.13% |
| Book Value per Share | -0.04 | -0.87 | 2.96 | 1.12 | 0.45 | 0.36 |
| Total Shareholders' Equity | -1.21M | -29.96M | 302.3M | 167.05M | 59.39M | 51.8M |
| Common Stock | 0 | 4K | 16K | 14K | 12K | 12K |
| Retained Earnings | -14.43M | -43.6M | -418.71M | -378.75M | -478.87M | -507.96M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 28K | 242K | -1.26M | -4.53M | -3.04M | -6.95M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Cash from Operations | 1.73M | -12.44M | -28.36M | -106.6M | 21.75M | 16.13M |
| Operating CF Margin % | 0.01% | -0.1% | -0.11% | -0.29% | 0.05% | 0.05% |
| Operating CF Growth % | - | -8.2% | -1.28% | -2.76% | 1.2% | -0.26% |
| Net Income | -1.64M | -29.18M | -375.11M | 44.38M | -100.12M | -29.1M |
| Depreciation & Amortization | 13.88M | 14.4M | 21.14M | 22.02M | 34.67M | 33.68M |
| Stock-Based Compensation | 103K | 363K | 12.42M | 28.5M | 22.54M | 26.7M |
| Deferred Taxes | -4.65M | -4.34M | -3.76M | -1.79M | 0 | -3.75M |
| Other Non-Cash Items | 1.94M | 8.9M | 335.62M | -59.42M | 41.29M | 16M |
| Working Capital Changes | -7.91M | -2.58M | -18.66M | -140.28M | 23.36M | -27.39M |
| Change in Receivables | -11.05M | 3.7M | -31.01M | -32.02M | 12.85M | 20.8M |
| Change in Inventory | -4.77M | -3.21M | -9.44M | -82.1M | 19.57M | -10.5M |
| Change in Payables | 4.31M | 4.89M | 10.52M | 1.61M | 15.78M | -43.78M |
| Cash from Investing | -12.48M | -3.82M | -37.73M | -18.87M | -31.51M | -6.79M |
| Capital Expenditures | -10.42M | -3.82M | -15.62M | -17.39M | -13.05M | -6.79M |
| CapEx % of Revenue | 0.06% | 0.03% | 0.06% | 0.05% | 0.03% | 0.02% |
| Acquisitions | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 781K | 0 | 0 | 0 |
| Cash from Financing | 14.58M | 18.27M | 959.03M | -205.24M | -37.45M | -158.34M |
| Debt Issued (Net) | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - |
| Other Financing | -1.92M | -1.3M | -503.86M | -45.24M | -1.82M | -302K |
| Net Change in Cash | - | - | - | - | - | - |
| Free Cash Flow | -8.69M | -16.25M | -43.98M | -123.99M | 8.7M | 9.34M |
| FCF Margin % | -0.05% | -0.14% | -0.17% | -0.34% | 0.02% | 0.03% |
| FCF Growth % | - | -0.87% | -1.71% | -1.82% | 1.07% | 0.07% |
| FCF per Share | -0.27 | -0.47 | -0.43 | -0.83 | 0.07 | 0.07 |
| FCF Conversion (FCF/Net Income) | -1.05x | 0.43x | 0.07x | -2.41x | -0.22x | -0.55x |
| Interest Paid | 15.73M | 13.54M | 10.25M | 0 | 9.38M | 8.01M |
| Taxes Paid | 861K | 2.43M | 1.7M | 0 | 2.27M | 2.8M |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -278.16% | 18.84% | -88.42% | -52.34% |
| Return on Invested Capital (ROIC) | 5.56% | -7.18% | -18.49% | -7.79% | -30.72% | -18.88% |
| Gross Margin | 63.92% | 56.43% | 68.65% | 68% | 38.97% | 54.53% |
| Net Margin | -0.98% | -24.5% | -145.63% | 12.09% | -25.16% | -8.7% |
| Debt / Equity | - | - | 2.47x | 4.50x | 12.67x | 10.97x |
| Interest Coverage | 0.79x | -0.81x | -3.39x | -1.93x | -9.59x | -6.51x |
| FCF Conversion | -1.05x | 0.43x | 0.07x | -2.41x | -0.22x | -0.55x |
| Revenue Growth | - | -28.53% | 118.39% | 40.67% | 8.78% | -16% |
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Consumables | 120.62M | 159.64M | 191.36M | 208.89M |
| Consumables Growth | - | 32.35% | 19.87% | 9.16% |
| Delivery Systems | 139.46M | 206.24M | 206.63M | 125.4M |
| Delivery Systems Growth | - | 47.88% | 0.19% | -39.31% |
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Americas | - | - | - | 216.99M |
| Americas Growth | - | - | - | - |
| EMEA | 46.96M | 68.33M | 88.09M | 71.63M |
| EMEA Growth | - | 45.50% | 28.92% | -18.68% |
| Asia Pacific | 43.7M | 54.31M | 82.19M | 45.67M |
| Asia Pacific Growth | - | 24.27% | 51.35% | -44.44% |
| UNITED STATES | 169.43M | 243.24M | 227.71M | - |
| UNITED STATES Growth | - | 43.57% | -6.39% | - |
The Beauty Health Company (SKIN) reported $301.9M in revenue for fiscal year 2024. This represents a 81% increase from $166.6M in 2019.
The Beauty Health Company (SKIN) saw revenue decline by 16.0% over the past year.
The Beauty Health Company (SKIN) reported a net loss of $11.7M for fiscal year 2024.
The Beauty Health Company (SKIN) has a return on equity (ROE) of -52.3%. Negative ROE indicates the company is unprofitable.
The Beauty Health Company (SKIN) generated $37.9M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.